Core Viewpoint - Jingye Intelligent announced a cash purchase of 51% equity in Hefei Shengwen Information Technology Co., Ltd. from Hangzhou Xingzhiyuan Holdings Co., Ltd. for 108 million yuan [1] Financial Performance - In the first half of the year, the company's main business revenue was 110 million yuan, an increase of 16.15% year-on-year [1] - The company reported a net profit attributable to shareholders of 5.5778 million yuan, a significant decline of 55.3% year-on-year [1] Regulatory Communication - The Shanghai Stock Exchange issued a regulatory work letter regarding the related party transaction of Jingye Intelligent, indicating ongoing communication between the regulatory body and the company [1] - The regulatory work letter does not imply any violations by the company but serves as a reminder or alert [1]

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

本资产评估报告依据中国资产评估准则编制 杭州景业智能科技股份有限公司拟收购 股权涉及的合肥市盛文信息技术有限 公司股东全部权益价值评估项目 资 产 评 估 报 告 坤元评报〔2025〕856 号 （共一册 第一册） 坤元资产评估有限公司 二〇二五年九月二十八日 | 报告编码: | 3333020001202500902 | | --- | --- | | 合同编号: | H-HZ25-001315 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 坤元评报（2025）856号 | | 报告名称: | 杭州景业智能科技股份有限公司拟收购股权涉及的合肥市盛文信 息技术有限公司股东全部权益价值评估项目资产评估报告 | | 评估结论: | 215,000,000.00元 | | 评估报告日: | 2025年09月28日 | | 评估机构名称: | 坤元资产评估有限公司 | | 签名人员: | 美静 (资产评估师) 正式会员 编号:33100009 | | | 邱琳 (资产评估师) 正式会员 编号: 33110006 | | | 姜静、邱琳已实名认可 | | 声明 1 | | | --- | - ...

Core Viewpoint - Hangzhou Jingye Intelligent Technology Co., Ltd. has received a regulatory work letter regarding its cash acquisition of equity in Hefei Shengwen Information Technology Co., Ltd., which will attract significant market attention towards this related party transaction [1] Group 1 - The regulatory work letter is specifically aimed at listed companies and was issued on September 30, 2025 [1] - The letter addresses the regulatory concerns surrounding the related party transactions of Hangzhou Jingye Intelligent Technology Co., Ltd. [1] - The market is expected to closely monitor the company's actions regarding the acquisition process and the handling of related party transactions [1]

Performance Forecasts - Yinglian Co., Ltd. expects a net profit growth of 1531.13% to 1672.97% year-on-year for the first three quarters [1] - Dalian Heavy Industry anticipates a net profit growth of 19.91% to 28.52% year-on-year for the first three quarters [1] Project Investments - Wharton Technology plans to invest in the enhancement of membrane materials and membrane components [1] - Jiufeng Energy intends to invest in a coal-to-natural gas project in Xinjiang [1] Contract Awards - Qiaoyin Co., Ltd. is pre-awarded a contract worth approximately 512 million yuan for integrated sanitation operations in Laishui County, Baoding City, Hebei Province [1] - Dash Smart signed a contract for a smart hospital project worth 113 million yuan [1] Equity Acquisitions - Conch New Materials plans to acquire 51% equity in North China Plastics [1] - Suochen Technology intends to acquire 60% equity in Likong Technology [1] - Jingye Intelligent plans to acquire 51% equity in Hefei Shengwen for 108 million yuan [1] - Landi Group plans to acquire 20.1667% equity in Jujia Technology for 121 million yuan [1] Share Buybacks - Hanshuo Technology plans to repurchase shares worth between 150 million yuan and 300 million yuan [2] - Youke De intends to spend between 8 million yuan and 10 million yuan on share buybacks [2] H-Shares - Jinghe Integrated Circuit has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [2] - Lingyi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange [2] - Changchun High-tech has submitted an application for the issuance of H-shares [2] Shareholding Changes - Senba Sensor's actual controller plans to reduce holdings by no more than 1.09% [3] - Erkang Pharmaceutical's controlling shareholder intends to reduce holdings by no more than 2.04% [3] - Andeli's BVI Donghua plans to reduce holdings by no more than 1.00% [3] - Zhiyang Innovation's controlling shareholder and its concerted actioner plan to reduce a total of no more than 4.225 million shares [3] - Xizi Clean Energy's chairman plans to increase holdings by 30 million to 50 million yuan [3] Other Activities - Luoxin Pharmaceutical plans to raise no more than 842 million yuan for innovative drug research and development projects [3] - Huaxin Xinchang has received project designation notification from Jiangqi Group [3] - Jinpu Garden plans to raise no more than 129 million yuan through a private placement to Nanjing Lisen [3]

Market Performance - The three major A-share indices collectively rose on September 29, with the ChiNext Index increasing by 2.74% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 21,781.43 billion yuan, an increase of over 12 billion yuan compared to the previous trading day [1] - More than 3,500 stocks closed higher, with 68 stocks hitting the daily limit up [1] Sector Performance - The leading sectors included metals such as zinc, nickel, and lead, while sectors like pork and military equipment restructuring saw significant declines [2] Institutional Ratings - A total of 21 buy ratings were issued by institutions today, covering 20 stocks, with three stocks receiving target price forecasts [3] - Stocks with buy ratings from institutions averaged a rise of 2.34%, outperforming the Shanghai Composite Index [4] Stock Highlights - Notable stocks that rose today included Lingyi Zhi Manufacturing and New Australia Holdings, with significant gains [5] - The top gainers included Feilihua, Luzhou Laojiao, and Huhua Electric, with increases of 5.24%, 4.3%, and 3.18% respectively [5] Institutional Buying and Selling - In the Dragon and Tiger list, 12 stocks saw net buying from institutions, with Tianqi Materials and Chuling Information receiving over 100 million yuan in net purchases [6] - The top net buying amounts included Tianqi Materials at 1 billion yuan and Lingyi Zhi Manufacturing at 987.78 million yuan [6] - Among the stocks sold by institutions, New Light Optoelectronics faced the highest net selling at 144 million yuan [7] Northbound Capital - Northbound funds saw net buying in 11 stocks, with Lingyi Zhi Manufacturing and Tianqi Materials leading the way [7] - Three stocks experienced net selling from northbound funds, with Wanxiang Qianchao facing a net sell of 105 million yuan [8] Company Announcements - Jingye Intelligent plans to acquire a 51% stake in Hefei Shengwen Information Technology for 1.08 billion yuan, aiming to enhance its military industry strategy [9] - Walton Technology is in the proposal stage for a project to enhance membrane materials and components, subject to internal approvals and market conditions [9] - ST Mingjiahui has received a court ruling for restructuring, which may lead to delisting risks if the restructuring fails [10] - Huayou Cobalt's subsidiary signed a supply agreement with LG Energy Solution for 76,000 tons of ternary precursor products from 2026 to 2030 [11] - China CRRC announced several major contracts totaling approximately 543.4 billion yuan, representing 22% of its projected 2024 revenue [11] - ST Mubang's actual controller is under investigation by the China Securities Regulatory Commission for failing to disclose non-operating fund transactions [11]

Mergers and Acquisitions - DiAo Micro plans to acquire equity in Rongpai Semiconductor through a combination of issuing shares and cash payment, with the stock suspended for up to 10 trading days [1] - Jingye Intelligent intends to purchase 51% of Hefei Shengwen for 108 million yuan, aiming to enhance its strategic presence in the military sector [2] - Guolin Technology is planning a cash acquisition of 91.07% of Xinjiang Kailianjie, which specializes in the production of maleic anhydride, potentially creating a synergistic relationship with its existing business [3] Shareholding Changes - Erkang Pharmaceutical's controlling shareholder plans to reduce holdings by up to 42 million shares, representing 2.04% of the total share capital [4] - Senba Sensor's actual controller's associated party intends to reduce holdings by no more than 308.69 thousand shares, accounting for 1.09% of the total share capital [5] - Zhiyang Innovation's controlling shareholder and associated parties plan to reduce holdings by up to 422.5 thousand shares, which is 1.82% of the total share capital, during a specified period [6] Regulatory Issues - Youkeshu announced that three shareholders are under investigation by the China Securities Regulatory Commission for failing to disclose significant information [7] - *ST Xingnong received a notice from the China Securities Regulatory Commission regarding an investigation for suspected information disclosure violations, while its operations remain normal [8] - *ST Mubang's actual controller is also under investigation by the China Securities Regulatory Commission for failing to disclose non-operational fund transactions [10]

合肥盛文专注于要地工程信息化与智能化产品的研发、生产及销售，核心产品涵盖国产自主可控的智能 化平台、智能周界安防系统、卫星反演系统、电磁场仿真评估系统以及密闭空间保障装备等，具备较强 的技术自主性和系统集成能力。同时，合肥盛文正在全面实施"一主三翼"业务战略，其中一主为综合信 息系统，三翼为智能伪装、重要目标防护和风电厂址电磁影响评估。 本次收购旨在加速公司在军工领域的战略布局与业务拓展。双方将通过深化特种机器人与智能化信息系 统的融合，在客户、市场、技术、产品和运营等方面形成多重协同效应，进一步提升公司在军工领域业 务的综合竞争力，推动公司业绩增长。 格隆汇9月29日丨景业智能(688290.SH)公布，为促进资源和产业整合，进一步优化产品布局，提升公司 市场竞争力，公司拟以自有资金通过现金支付的方式收购行之远持有的合肥盛文51%股权。以2025年8 月31日为评估基准日，合肥盛文100%股权的评估值为人民币21,500万元，本次评估增值率为464.97%。 经交易各方协商一致，合肥盛文51%股权交易价格为人民币10,800万元。 ...

中信证券股份有限公司 关于杭州景业智能科技股份有限公司 现金收购合肥市盛文信息技术有限公司 51%股权 暨关联交易的核查意见 中信证券股份有限公司（以下简称"中信证券""保荐人"）作为杭州景业 智能科技股份有限公司（以下简称"景业智能""公司"）首次公开发行股票并 在科创板上市、以简易程序向特定对象发行人民币普通股（A 股）股票的保荐人， 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》 《上海证券交易所上市公司自律监管指引第 5 号——交易与关联交易》及《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等法律法规的有 关规定，对景业智能现金收购合肥市盛文信息技术有限公司 51%股权暨关联交易 进行了审慎核查，具体情况如下： 一、关联交易概述 为促进资源和产业整合，进一步优化产品布局，提升公司市场竞争力，公司 拟以自有资金通过现金支付的方式收购杭州行之远控股有限公司（以下简称"行 之远"）持有的合肥市盛文信息技术有限公司（以下简称"合肥盛文""标的公 司"）51%股权。 行之远系公司控股股东，属于关联法人，根据《上海证券交易所科创板股票 上市规则》等规定，本次收购构成 ...

目 录 | 一、审计报告……………………………………………………… 第 | 1—3 | 页 | | --- | --- | --- | | 二、财务报表……………………………………………………… 第 | 4—7 | 页 | | （一）资产负债表………………………………………………… | 第 4 | 页 | | （二）利润表……………………………………………………… | 第 5 | 页 | | （三）现金流量表………………………………………………… | 第 6 | 页 | | （四）所有者权益变动表………………………………………… | 第 7 | 页 | | 三、财务报表附注………………………………………………… 第 | 8—49 | 页 | | 四、证书附件………………………………………………………第 | 50—53 | 页 | 审 计 报 告 天健审〔2025〕16438 号 合肥市盛文信息技术有限公司全体股东： 一、审计意见 我们审计了合肥市盛文信息技术有限公司（以下简称合肥盛文公司）财务报 表，包括 2024 年 12 月 31 日、2025 年 8 月 31 日的资产负债表，2024 年度、2025 ...